The reassessment of their positions is being driven by unpredictability over tariffs, rather than the levies President Donald ...

Britain’s economy grew more than expected in the first three months of the year, official figures show, as businesses braced ...

A growing disconnect between insurance market capacity and lender requirements is squeezing real estate borrowers and leaving ...

For the second time in a span of a month, broking giant Marsh has launched a lawsuit alleging employee and client poaching, ...

Shares of Willis Towers Watson PLC WTW slipped 1.06% to $304.21 Tuesday, on what proved to be an all-around mixed trading ...

In a startling projection for 2025, insurance provider Willis Towers Watson anticipates an 18.3 percent rise in medical ...

Former pensions minister Baroness Ros Altmann has called for a reshaping of pension tax relief rules to incentivise more UK ...

We recently published a list of Billionaire David Abrams’ 10 Stock Picks with Huge Upside Potential. In this article, we are ...

According to Reuters, a study commissioned by a drug lobbying group found that a 25% tariff on pharmaceuticals, which are normally exempt from tariffs, would increase drug costs in the U.S. by $51 ...

MY Dream In A Shoebox (Mdias), the annual advocacy campaign of strategic marketing agency TeamAsia, concluded its 16th year ...

Erich Mische is CEO of SAVE - Suicide Awareness Voices of Education. Jonathan Oppenheim is Head of North America Construction ...

A shareholder suit over the 2016 deal that formed Willis Towers Watson Plc sought compensatory damages over inadequate disclosures, not insufficient deal value, and should be covered by insurance, the ...